Atlas Trials

Weijia Fang, MD

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Weijia Fang, MD

RecordFirmDate
An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors. (NCT07420010)Weijia Fang, MD2026-03-15
Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors (NCT06821048)Weijia Fang, MD2024-07-24
Neoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma ：A Single-arm, Prospective, Phase II Trial (NCT05862168)Weijia Fang, MD2023-05-08
A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors (NCT05396300)Weijia Fang, MD2022-05-25
Study of LD013 in Subjects With Refractory or Relapsed Mesothelin -Positive Ovarian Cancer (NCT05372692)Weijia Fang, MD2022-04-12
CART Therapy in GUCY2C-positive Digestive Tract Tumors (NCT04652219)Weijia Fang, MD2020-10-10

Track Weijia Fang, MD automatically

Every clearance here is in the API, with alerts when new ones post.